专利号:US-10925977-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications 发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S 权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS 摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
专利号:US-RE28647-E 优先权日:1971-06-02 标 题:Preparation of 3-4 dideoxykanamycin B active against resistant bacteria 摘要:Synthesis of 3''-4''-dideoxykanamycin B which comprises protecting the amino and all or a part of the hydroxyl groups other than 3'' and 4''-hydroxyl groups of kanamycin B, sulfonylating 3''- and 4''hydroxyl groups to give a derivative having disulfonic ester groups, removing said ester groups to give 3''-4''-unsaturated compound, reducing said compound and finally removing the residual protecting groups.
专利号:US-8147805-B2 优先权日:2005-01-05 标题:Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications 发明人:YANG DAVID; YU DONGFANG; CHANDA MITHU; AZHDARINIA ALI; OH CHANGSOK; KIM E EDMUND 权利人:YANG DAVID; YU DONGFANG; CHANDA MITHU; AZHDARINIA ALI; OH CHANGSOK; KIM E EDMUND; UNIV T EXAS SYSTEM BOARD OF REGENTS 摘要:Compositions and methods for dual imaging and for dual chemotherapy and radiotherapy are disclosed. More particularly, the invention concerns compounds comprising the structure X 1 —Y—X 2 , wherein Y comprises two or more carbohydrate residues covalently attached to one another, X 1 and X 2 are diagnostic or therapeutic moieties covalently attached to Y, provided that when Y does not comprise a glucosamine residue, X 1 and X 2 are diagnostic moieties. The present invention also concerns methods of synthesis of these compounds, application of such compounds for dual imaging and treatment of hyperproliferative disease, and kits for preparing a radiolabeled therapeutic or diagnostic compound.
专利号:US-10472663-B2 优先权日:2015-01-21 标 题:Procedure for the rapid determination of bacterial susceptibility to antibiotics that inhibit protein synthesis 发明人:FERNÃ?NDEZ GARCÃ?A JOSÉ LUIS; GOSÃ?LVEZ BERENGUER JAIME; BOU ARÉVALO GERMÃ?N; TAMAYO NOVAS MARIA; SANTISO BRANDARIZ REBECA; OTERO FARIÑA FÃ?TIMA MARÃ?A 权利人:ABM TECH LLC 摘要:The present invention relates to a method for the rapid evaluation of bacterial susceptibility or non-susceptibility of bacteria to antibiotics that inhibit protein synthesis. The rationale is to identify bacterial responses that depend or are influenced by protein synthesis. If this response is prevented or reduced by the antibiotic that inhibits the protein synthesis, the bacteria are susceptible to this antibiotic. Otherwise, if the response keeps similar despite the incubation with the antibiotic, the bacteria are not susceptible or resistant to this antibiotic. These responses could be determined at the DNA lev-el, cell wall level, morphological level or any other experimental approach, including metabolic, bio-chemical, physiological or genetic processes.
专利号:US-10814013-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
专利号:AU-2007308022-A2 优先权日:2006-10-05 标题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
1: Umemura E, Sakamoto Y, Takahashi Y, Miyake T. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B. J Antibiot (Tokyo). 2015 Jun;68(6):421-3. doi: 10.1038/ja.2015.6. Epub 2015 Feb 25. French. doi: 10.1038/ja.2015.61. Epub 2015 May 20. Review. doi: 10.1128/AAC.03354-14. Epub 2014 Aug 4. 7: Takeshima Y. [Genetic Diagnosis and Molecular Therapies for Duchenne Muscular Dystrophy]. Rinsho Byori. 2015 Oct;63(10):1194-201. Review. Japanese. German. doi: 10.1016/j.jiac.2014.05.007. Epub 2014 Jun 25. doi: 10.3346/jkms.2015.30.6.688. Epub 2015 May 13. 12: Komiya I, Murata S, Umemura K, Tomono N, Kikai S, Fujita M. Acute toxicity and pharmacokinetics of dibekacin mice. J Pharmacobiodyn. 1981 May;4(5):356-61. doi: 10.1016/j.jcjo.2015.05.006. Epub 2015 Jul 23. doi: 10.1128/AAC.04839-14. Epub 2015 Mar 23.
合成参考文献
参考文献:10.1007/bf01718247 摘要:Lobert PE, Hober D, Delannoy AS, Wattré P. Evidence that neomycin inhibits human cytomegalovirus infection of fibroblasts. Arch Virol. 1996;141(8):1453–62. doi: 10.1007/bf01718247. 摘要:Hamada Y, Tamura K, Koyama I, Seki M, Yago K, Sunakawa K, Kuroyama M. Evaluation of arbekacin anti-MRSA agents for adult in Japan. Jpn J Antibiot. 2012 Aug;65(4):221–34. 摘要:Kimura M, Yamagishi Y, Kawasumi N, Mikamo H. [Clinical investigation of arbekacin sulfate based on Cmax/MIC]. Jpn J Antibiot. 2012 Aug;65(4):263–9. 参考文献:10.1007/s10156-012-0519-z 摘要:Matsumoto T, Hanaki H, Kimura T, Nemoto M, Higashihara M, Yokota H, Oda S, Akiyama N, Miyao N, Yoshida M, Yukioka T, Soma K, Ohyashiki K, Suzuki Y, Arai T, Ikegami K, Ichiwata T, Otsuka Y, Kobayashi M, Totsuka K, Sunakawa K; ABK Dose Finding Study Group. Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study. J Infect Chemother. 2013 Feb;19(1):128–37. doi: 10.1007/s10156-012-0519-z.